Heparin Sodium Injection
NDC Package 87188-102-90

11-digit billing NDC: 87188010290
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Heparin Sodium injection is indicated for:Prophylaxis and treatment of venous thrombosis and pulmonary embolismPrevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic diseaseAtrial fibrillation with embolizationTreatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation)Prevention of clotting in arterial and cardiac surgeryProphylaxis and treatment of peripheral arterial embolismAnticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. This formulation utilizes a injection delivery system. Marketed by Plano Pharmaceuticals Inc., this product is identified by NDC 87188-102 and is authorized under FDA application ANDA091682.

Identification & Billing

NDC Package Code
87188-102-90
Package Description
25 VIAL, MULTI-DOSE in 1 CARTON / 1 mL in 1 VIAL, MULTI-DOSE (87188-102-01)
Product Code
87188-102
11-Digit Billing Format
87188010290
RxNorm Crosswalk
RxCUI: 1361615 - heparin sodium, porcine 5000 UNT/ML Injectable Solution

Clinical Specifications

Proprietary Name
Heparin Sodium
Non-Proprietary Name
Heparin Sodium
Substance Name
Heparin Sodium
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
  • Intravenous - Administration within or into a vein or veins.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
HEPARIN SODIUM 5000 [USP'U]/mL
Pharmacologic Class
Usage Information
Heparin sodium injection is indicated for:Prophylaxis and treatment of venous thrombosis and pulmonary embolismPrevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic diseaseAtrial fibrillation with embolizationTreatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation)Prevention of clotting in arterial and cardiac surgeryProphylaxis and treatment of peripheral arterial embolismAnticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures

Regulatory & Marketing

Labeler Name
Plano Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA091682
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-08-2011
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87188-102-90 identifies a specific commercial package of 25 vial, multi-dose in 1 carton / 1 ml in 1 vial, multi-dose (87188-102-01) of Heparin Sodium, a human prescription drug labeled by Plano Pharmaceuticals Inc.. This injection is formulated for intravenous; subcutaneous use and contains heparin sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Plano Pharmaceuticals Inc. on June 08, 2011. The current certification is valid through December 31, 2027.

How is this Plano Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87188010290. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87188-102-90
11-Digit CMS (5-4-2)
87188-0102-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.